Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
99
100
Next >
Zimmer Biomet To Stop Selling CPT Hip Implant System By End Of 2024 Due To High Fracture Risks
September 18, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ZBH
Merck's Keytruda Secures First FDA-Approval For Rare Form Aggressive Cancer
September 18, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
MRK
AstraZeneca's Asthma Drug Gets FDA Approval For Rare Disease Of Blood Vessel Inflammation
September 18, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
AZN
GSK
Applied Therapeutics Stock Soars As FDA Scraps Panel Meeting For Its Inherited Metabolic Disorder Drug
September 18, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
APLT
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp.’s (NASDAQ: TNXP) TNX-801 Positioned as Viable Contender in Global Fight Against Mpox
September 18, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
TNXP
FDA Registered OTC Hearing Aids & Saunas: Daily Use & Care Guide Released
September 13, 2024
Via
Press Release Distribution Service
Exposures
Product Safety
NRx Pharmaceuticals NRXP: Prominently Featured in Psychiatrist.com; Article Titled "How NRx Could Upend the Fight Against Depression and Suicide"
September 11, 2024
Via
PRLog
Exposures
Product Safety
Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children
September 18, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
VVOS
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Awarded First-Ever FDA Clearance for Pediatric Treatment of Sleep Apnea, Snoring
September 18, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
VVOS
GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults
September 18, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
AGEN
GSK
Top-Rated Hartford-Based Firm, Freed Marcroft Divorce & Family Law, Name Two Talented Team Members As Partner
September 18, 2024
Via
Syndication Cloud
Topics
Product Recall
Exposures
Legal
Product Safety
Why 3D Systems (DDD) Stock Is Trading Higher
September 17, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
DDD
The only FDA-approved nasal spray medication proven to reduce symptoms in people living with treatment-resistant depression
September 17, 2024
Via
Brandpoint
Exposures
Product Safety
Eli Lilly Scores FDA Approval For Eczema Treatment Ebglyss
September 16, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
LLY
Creative Diagnostics Announces New Zearalenone Test Reagents for Food Safety Applications
September 16, 2024
Via
AB Newswire
Topics
Supply Chain
Exposures
Ethanol
Product Safety
Supply Chain
Ascendis Pharma's Rare Dwarfism Candidate Shows Promise In Trial, FDA Submission Expected Next Year
September 16, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ASND
Back-To-Back FDA Approvals For Roche's Two Under-The-Skin Injections
September 16, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
RHHBY
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Announces Upcoming In-Person FDA Meeting to Discuss CNM-Au8
September 16, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
CLNN
Moderna’s Recent Drop: 4 Reasons Bulls See Opportunity
September 16, 2024
Via
MarketBeat
Exposures
COVID-19
Product Safety
Tickers
MRK
MRNA
FDA Removes Partial Hold On Zentalis Pharmaceuticals' Azenosertib Studies In Patients With Gynecological Cancers
September 16, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ZNTL
UPTX Top Trader | Fly: How to Double Your Investment in 12 Months
September 13, 2024
Via
Binary News Network
Topics
Product Recall
Exposures
Legal
Product Safety
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
September 12, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ATAI
CMPS
MBIO
NUMIF
FDA Approves First OTC Hearing Aid Software Compatible With Apple's AirPods Pro
September 12, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
AAPL
North Fish USA Inc. Recalls Cold Smoked Capelin Due to Potential Botulism Risk
September 12, 2024
Via
AB Newswire
Topics
Product Recall
Exposures
Legal
Product Safety
Alnylam Stock Soars 65%: Find Out What’s Behind the Gains
September 12, 2024
Via
MarketBeat
Exposures
Product Safety
Tickers
ALNY
PFE
Multidisciplinary Association For Psychedelic Studies Eyes State-Level Legalization After FDA Denial Of MDMA Therapy
September 11, 2024
Via
Benzinga
Exposures
Product Safety
Metals in Tampons: FDA Initiates New Safety Measures and Testing
September 11, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
EPC
JNJ
KMB
PG
Novo Nordisk Reports Positive Results Of Weight-Loss Drug Liraglutide For Children As Young As 6, Eyes FDA And EMA Approval
September 11, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
HIMS
LLY
NVO
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Names Seasoned Veteran as New EVP of Commercial Operations
September 10, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
TNXP
BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) Reports on FDA Pre-IND Meeting to Advance Development of Lead Program
September 10, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
SILO
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.